4.7 Article

Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Current approved options for treating patients with multiple sclerosis

SA Rizvi et al.

NEUROLOGY (2004)